“14> ’0 '2
1 - th; N05 1520/3
571/; 1 WM (157- l 14/ '{////l

 

 

PATIENT HISTORY:

CHIEF COMPUIINT/ PRE-OP/ POST-OP DIAGNOSIS: Endometrial cancer.

LMP DATE: Postmenopausal. w

PROCEDURE: Total ademinaI hys'tereé‘omy. bilateral salpingo-oophorectomy. pelvic and periaortic lymph node dissection.
SPECIFIC CLINICAL QUESTION: Not provided.

OUTSIDE TISSUE DIAGNOSIS: N0.

PRIOR MALIGNANCY: No.

CHEMOFIADIATION THERAPY: No.

OTHER DISEASES: No.

CASE SYNOPSIS:
SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL CARCINOMA a. CARCINOSARCOMA: HYSTERECTOMY
. SPECIMENS
TUMOR TYPE: Ensiometroid adenocarcinoma, NOS
HISTOLOGIC GRADE (epithelial neoplastﬁ) [combined architecturaland nuclear]:
Well differenﬁatew (FIGO 1L“)

 

ARCHITECTURAL GRADE: Well dlﬁerentiafé‘d' """
NUCLEAR GRADE: Grade 1
TUMOR SIZE: Maximum dimension: 25 mm

PERCENT OF ENDOMETRIAL SURFACE INVOLVEMENT:
Anterior endomyomelrlum: 30 %, Posterior endomyometrium: 30 %

DEPTH OF INVASION: Less than 1/2 thickness of myometrium
MARGINS OF RESECTION: Vaginal margin is negative for tumor, Parametrium margin is negative for Iumor
ANGIOLYMPHATIC INVASION: No

PRE—NEOPLASTIC CONDITIONS: Complex endometrial hyperplasia without atypia

OTHER: Adenomyosis. Leiomyoma

LYMPH NODES POSITIVE: Number of lymph nodes positlve: O
LYMPH NODES EXAMINED: Total number of lymph nodes examined: 9
T STAGE, PATHOLOGIC: pT1a

N STAGE, PATHOLOGIC: pNO

M STAGE, PATHOLOGIC: Not applicable

FIGO STAGE: IA

 

UUID:42E7D5FF-18CD-40EA-9518-939732BCA635
TCGA-BG-ABW-OlA-PR Redacted

IIIllllllllllllllllllll|||||||llllllllllllllllllllllllllllllll I
III ||l|l||||l|l|||||||lIII|||l|l|l||||||||||l||l|||||||||l|l||
‘\ III ”III“! ||||||||||||l || ||II|| I Illlll || | I III | |||||||||||| ||

 

Crkcrla

Pi Tumor Site
HIPAA
P'Iur

Case is
Reviewer

 

